Class information for:
Level 2: ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
2161 4516 27.5 74%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)



ID, lev.
above
Publications Label for level above
464 22271 CARCINOMA RENAL CELL//ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS

Classes in level below (level 1)



ID, lev. below Publications Label for level below
3350 1928 TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX//SUBEPENDYMAL GIANT CELL ASTROCYTOMA
5587 1537 ANGIOMYOLIPOMA//PECOMA//EPITHELIOID ANGIOMYOLIPOMA
15053 665 LYMPHANGIOLEIOMYOMATOSIS//MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA//PULMONARY LYMPHANGIOLEIOMYOMATOSIS
22256 331 BIRT HOGG DUBE SYNDROME//FOLLICULIN//FIBROFOLLICULOMA
35012 55 LIPEDEMATOUS ALOPECIA//LIPEDEMATOUS SCALP//SCALP THICKENING

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ANGIOMYOLIPOMA Author keyword 983 85% 12% 526
2 TUBEROUS SCLEROSIS Author keyword 760 69% 14% 642
3 TUBEROUS SCLEROSIS COMPLEX Author keyword 419 71% 8% 340
4 LYMPHANGIOLEIOMYOMATOSIS Author keyword 414 83% 5% 237
5 PECOMA Author keyword 262 87% 3% 128
6 SUBEPENDYMAL GIANT CELL ASTROCYTOMA Author keyword 190 90% 2% 82
7 TUBERIN Author keyword 138 76% 2% 97
8 HAMARTIN Author keyword 131 87% 1% 65
9 PERIVASCULAR EPITHELIOID CELL Author keyword 128 94% 1% 46
10 EPITHELIOID ANGIOMYOLIPOMA Author keyword 112 89% 1% 50

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 ANGIOMYOLIPOMA 983 85% 12% 526 Search ANGIOMYOLIPOMA Search ANGIOMYOLIPOMA
2 TUBEROUS SCLEROSIS 760 69% 14% 642 Search TUBEROUS+SCLEROSIS Search TUBEROUS+SCLEROSIS
3 TUBEROUS SCLEROSIS COMPLEX 419 71% 8% 340 Search TUBEROUS+SCLEROSIS+COMPLEX Search TUBEROUS+SCLEROSIS+COMPLEX
4 LYMPHANGIOLEIOMYOMATOSIS 414 83% 5% 237 Search LYMPHANGIOLEIOMYOMATOSIS Search LYMPHANGIOLEIOMYOMATOSIS
5 PECOMA 262 87% 3% 128 Search PECOMA Search PECOMA
6 SUBEPENDYMAL GIANT CELL ASTROCYTOMA 190 90% 2% 82 Search SUBEPENDYMAL+GIANT+CELL+ASTROCYTOMA Search SUBEPENDYMAL+GIANT+CELL+ASTROCYTOMA
7 TUBERIN 138 76% 2% 97 Search TUBERIN Search TUBERIN
8 HAMARTIN 131 87% 1% 65 Search HAMARTIN Search HAMARTIN
9 PERIVASCULAR EPITHELIOID CELL 128 94% 1% 46 Search PERIVASCULAR+EPITHELIOID+CELL Search PERIVASCULAR+EPITHELIOID+CELL
10 EPITHELIOID ANGIOMYOLIPOMA 112 89% 1% 50 Search EPITHELIOID+ANGIOMYOLIPOMA Search EPITHELIOID+ANGIOMYOLIPOMA

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PULMONARY LYMPHANGIOLEIOMYOMATOSIS 568 88% 6% 271
2 RENAL ANGIOMYOLIPOMA 386 85% 4% 202
3 LYMPHANGIOMYOMATOSIS 347 81% 5% 206
4 HAMARTIN 204 87% 2% 100
5 TUBEROUS SCLEROSIS COMPLEX 194 35% 10% 454
6 LYMPHANGIOLEIOMYOMATOSIS 174 59% 4% 194
7 SUGAR TUMOR 167 81% 2% 101
8 ANGIOMYOLIPOMA 161 50% 5% 232
9 MYOMELANOCYTIC TUMOR 147 94% 1% 51
10 TSC1 142 72% 2% 111

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
The tuberous sclerosis complex 2006 580 94 83%
Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy 2015 3 63 89%
Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in Tuberous Sclerosis Complex 2015 2 12 83%
Tuberous sclerosis 2008 221 136 82%
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis 2010 96 90 93%
Disentangling the heterogeneity of autism spectrum disorder through genetic findings 2014 36 74 32%
PEComa: what do we know so far? 2006 176 70 99%
Birt-Hogg-Dube syndrome: diagnosis and management 2009 89 72 83%
Advances in the treatment of tuberous sclerosis complex 2015 1 39 97%
Tuberous sclerosis: from tubers to mTOR 2003 206 53 75%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 TUBEROUS SCLEROSIS CLIN 21 90% 0.2% 9
2 PENN EPILEPSY 13 41% 0.6% 25
3 BATH UNIT PAEDIAT 8 60% 0.2% 9
4 PNEUMOTHORAX 8 60% 0.2% 9
5 CAROL JAMES HERSCOT TUBEROUS SCLEROSIS COMP 6 71% 0.1% 5
6 EXPERTISE NEURODEV DISORDERS 6 71% 0.1% 5
7 NEURODEV SERV NDS 4 67% 0.1% 4
8 PULM CRIT CARE MED BRANCH 4 13% 0.7% 31
9 CLIN INTERSTITIAL RARE LUNG DIS 3 100% 0.1% 3
10 EXPT MED MED ONCOL 3 100% 0.1% 3

Related classes at same level (level 2)



Rank Relatedness score Related classes
1 0.0000013583 CARCINOMA RENAL CELL//PARTIAL NEPHRECTOMY//NEPHRECTOMY
2 0.0000012624 CARDIAC MYXOMAS//MYXOMA//PAPILLARY FIBROELASTOMA
3 0.0000011693 PTEN//MTOR//LHERMITTE DUCLOS DISEASE
4 0.0000010029 NEUROFIBROMATOSIS TYPE 1//NEUROFIBROMATOSIS//NF1
5 0.0000008145 ENDOMETRIAL STROMAL SARCOMA//LEIOMYOSARCOMA//UTERINE SARCOMA
6 0.0000007880 EPILEPSY SURGERY//TEMPORAL LOBE EPILEPSY//EPILEPSY
7 0.0000006417 RENAL TRAUMA//RENAL ARTERIOVENOUS FISTULA//PERCUTANEOUS RENAL BIOPSY
8 0.0000005423 LIPOBLASTOMA//LIPOSARCOMA//LIPOMA
9 0.0000005259 NEPHROGENIC ADENOMA//URETHRAL DIVERTICULUM//SEMINAL VESICLE CYST
10 0.0000004936 AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE//POLYCYSTIC KIDNEY DISEASE//ADPKD